Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis

Abstract: The interaction between intestinal microecological dysregulation, altered inflammatory factors, and cirrhosis is unclear. The aim of this systematic review and meta-analysis was to synthesize the results of previous studies to assess the efficacy of probiotics in the treatment of cirrhosis and their effect on inflammatory factors, as well as to explore the relationship between gut microecological dysregulation and liver disease to gain a deeper understanding of this interaction. Up to December 2022, eligible studies were identified by searching the following databases: National Knowledge Infrastructure (CNKI), Wanfang Data, Web of Science, PubMed, Embase, Medline, and the Cochrane Library. Statistical analysis was performed using software RevMan Version 5.4. A total of 33 eligible randomized controlled trials were included in the study, and data on probiotic strains, duration of intervention, measures in the control group, and outcomes were extracted and evaluated. Compared to the control group, the experimental group had significant improvements in overall efficacy. The results of the meta-analysis revealed that probiotic use significantly decreased biochemical parameters for liver function, including aspartate transaminase, alanine aminotransferase, and total bilirubin. Similar result was obtained in interleukin-6, tumor necrosis factor-α, and endotoxin. However, probiotic intervention did not significantly affect interleukin-2 and interleukin-10. The current meta-analysis illustrates that probiotic supplementation reduces inflammatory markers and biochemical parameters for liver function in patients with cirrhosis, suggesting that probiotic management may be a novel treatment for cirrhosis. Furthermore, the interaction of the gut microbiota, associated metabolites, and inflammation factors with cirrhosis may provide a promising therapeutic target for the pharmacological and clinical treatment of cirrhosis.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis ; volume:18 ; number:1 ; year:2023 ; extent:25
Open life sciences ; 18, Heft 1 (2023) (gesamt 25)

Creator
Xia, Qinglan
Lei, Yumeng
Wang, Jiadun
Wang, Qiang

DOI
10.1515/biol-2022-0741
URN
urn:nbn:de:101:1-2023101914203508677367
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
05.11.2025, 3:11 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Xia, Qinglan
  • Lei, Yumeng
  • Wang, Jiadun
  • Wang, Qiang

Other Objects (12)